Published in J Bacteriol on August 01, 1957
TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH. Br Med J (1963) 6.83
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Biology of Bordetella bronchiseptica. Microbiol Rev (1980) 5.31
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis. Proc Natl Acad Sci U S A (1989) 3.13
Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1981) 2.94
Fluorescent antibody staining and agglutination reactions in Bordetella pertussis cultures. J Bacteriol (1962) 2.92
Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis. Bacteriol Rev (1968) 2.77
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis. Infect Immun (1982) 2.47
Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes. Infect Immun (1989) 2.40
Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18
Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I. J Clin Microbiol (1983) 2.17
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92
THE CONTENT OF ANTIGENS 1,2 AND 3 IN STRAINS OF BORDETELLA PERTUSSIS AND IN VACCINES. Can Med Assoc J (1965) 1.92
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Specific lipopolysaccharides of Bordetella. Biochem J (1960) 1.53
Mouse-protective properties of Bordetella pertussis serotypes in passive tests. J Bacteriol (1967) 1.34
Bordetella pertussis serotypes in the United States. Appl Microbiol (1969) 1.29
Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1987) 1.26
The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis. Immunology (1969) 1.25
Histamine-sensitizing factor, mouse-protective antigens, and other antigens of some members of the genus Bordetella. J Bacteriol (1969) 1.20
Bordetella pertussis culture having only species factor 1. J Bacteriol (1966) 1.18
Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection. J Hyg (Lond) (1973) 1.16
Pertussis: the disease and new diagnostic methods. Clin Microbiol Rev (1988) 1.16
Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection. J Clin Microbiol (1981) 1.13
A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis. J Hyg (Lond) (1982) 1.11
Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10
The stability of the serotypes of Bordetella pertussis with particular reference to serotype 1,2,3,4. J Hyg (Lond) (1976) 1.09
Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect Immun (2008) 1.09
The importance of agglutinin production in mice in the determination of the definitive serotype of Bordetella pertussis. J Hyg (Lond) (1976) 1.06
Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol (2008) 1.02
Mutant of Bordetella pertussis which lacks ability to produce filamentous hemagglutinin. Infect Immun (1982) 1.00
Protection against experimental Bordetella bronchiseptica infection in mice by active immunization with killed vaccine. Infect Immun (1983) 0.92
Bordetella pertussis serotypes in Canada. Can Med Assoc J (1978) 0.88
Antigens of Bordetella pertussis V. Separation of Agglutinogen 1 and Mouse-Protective Antigen. Infect Immun (1971) 0.87
Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s. J Bacteriol (1966) 0.85
Fimbrial typing of Bordetello pertussis isolates: agglutination with polyclonal and monoclonal antisera. J Clin Microbiol (2001) 0.84
Laboratory diagnosis of whooping-cough or Bordetella infections. Bull World Health Organ (1960) 0.80
Involvement of multiple distinct Bordetella receptor proteins in the utilization of iron liberated from transferrin by host catecholamine stress hormones. Mol Microbiol (2012) 0.79
Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines. Epidemiol Infect (1988) 0.75
Serological studies on H. pertussis H. parapertussis and H. bronchisepticus. Acta Pathol Microbiol Scand (1953) 7.00
A study of the stability of pertussis vaccine under different conditions of storage. Am J Public Health Nations Health (1955) 3.03
Fluorescent antibody staining and agglutination reactions in Bordetella pertussis cultures. J Bacteriol (1962) 2.92
Fluorescent antibody techniques. Methods for identification of Bordetella pertussis. Am J Dis Child (1961) 2.50
Comparison of pertussis cultures by mouse protection and virulence tests . Am J Public Health Nations Health (1949) 2.15
Whooping cough studies in Grand Rapids and Kent County. J Mich State Med Soc (1958) 1.57
Measuring the extent of immunization in Grand Rapids and Kent County, Michigan. Public Health Rep (1952) 1.48
Studies on kuru. III. Patterns of kuru incidence: demographic and geographic epidemiological analysis. Am J Trop Med Hyg (1961) 1.28
STABILIZATION OF PERTUSSIS VACCINE IN THE PRESENCE OF BENZETHONIUM CHLORIDE. J Bacteriol (1964) 1.26
Incidence of parapertussis in the Grand Rapids area as indicated by 16 years' experience with diagnostic cultures. Am J Public Health Nations Health (1952) 1.20
Antigenic relationships of Haemophilus pertussis, the parapertussis bacillus, and Brucella bronchiseptica as shown by cross protection tests in mice. J Bacteriol (1953) 1.17
CULTURE AND FLUORESCENT-ANTIBODY METHODS IN DIAGNOSIS OF WHOOPING COUGH. J Bacteriol (1963) 1.06
A controlled study of an intensive treatment program for hospitalized geriatric patients. J Am Geriatr Soc (1958) 0.87
Digitalis tolerance in dogs following extracorporeal circulation. Surg Forum (1961) 0.81
Proof of the early utilization of fat administered intravenously into human subjects. Exp Med Surg (1951) 0.81
Electroencephalograms during hypoxia in healthy men. Response characteristic for normal aging. Arch Neurol (1961) 0.78
PRESENCE OF A PANCREATIC GASTRIC SECRETOGOGUE AND PARIETAL CELL PROLIFERATION AFTER PANCREATIC DUCT LIGATION. Surg Forum (1964) 0.78
Reenforcing or booster injection of pertussis vaccine in previously immunized children of kindergarten age. Am J Dis Child (1946) 0.76
Advising patients regarding travel in Latin America. Tex State J Med (1953) 0.75
Glomerular lipoidosis in intercapillary glomerulosclerosis. Am Heart J (1948) 0.75
Wilms tumor with unusual hematological findings in an infant 40 days old. Tex Rep Biol Med (1949) 0.75
Allergy in children as related to altitude. Ann Allergy (1948) 0.75
Electroencephalograms during hypercapnia. Response characteristi for normal aging subjects. Arch Neurol (1963) 0.75
Evidence on the influence of altitude on allergic symptoms in children. Tex Rep Biol Med (1946) 0.75
Disseminated Cryptococcus neoformans; case report. New Orleans Med Surg J (1949) 0.75
Present day concepts of allergy. Pediatrics (1950) 0.75
Mouse protection tests in the study of pertussis vaccine; a comparative series using the intracerebral route for challenge. Am J Public Health Nations Health (1947) 0.75
Gonococcus examinations; a comparison of slides, mailed slants and immediate plates. Am J Public Health Nations Health (1946) 0.75
The biosynthesis of trimethylamine-N-oxide. Biochim Biophys Acta (1960) 0.75
Serum protein levels and calculated osmotic pressures in tuberculosis: I. Correlation of these values with the severity of the disease. J Thorac Surg (1951) 0.75
Comparison of charcoal agar and Petragnani's medium for the isolation of Mycobacterium tuberculosis. Am Rev Respir Dis (1961) 0.75